EFNA5 and renal carcinoma: Dysfunction of the Rags can also promote tumorigenesis, as seen in the case of RagC mutations in follicular lymphoma and mutations of FLCN, a RagC/D activator, in BHD syndrome, which is associated with renal cancer.